Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Aprotinin coronary artery bypass

Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery a systematic review and meta-analysis of randomized clinical trials. J. Thorac. Cardiovasc. Surg. 2004 128 442-448. [Pg.1713]

Levy JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, Rosengart TK, Murray J, Clark RE, Smith P. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995 92(8) 2236 4. [Pg.333]

Schneeweiss S, Seeger JD, Landon J, Walker AM. 2008. Aprotinin during coronary-artery bypass grafting and risk of death. N. Engl.. Med. 358 771-783. [Pg.169]

Bittner HB, Lange M, Lemke J, Rastan A, Mohr FW. Aprotinin-associated risks in off-pump coronary artery bypass grafting. Thorac Cardiovasc Surg 2009 57(8) 455-9. [Pg.738]

See other pages where Aprotinin coronary artery bypass is mentioned: [Pg.782]    [Pg.1710]    [Pg.333]    [Pg.88]    [Pg.414]    [Pg.287]    [Pg.725]    [Pg.725]   


SEARCH



Aprotinin

Aprotinine

Bypass

Bypassing

Coronary artery

Coronary artery bypass

© 2024 chempedia.info